170 related articles for article (PubMed ID: 32803671)
21. Patient-level meta-analysis of 999 claudicants undergoing primary femoropopliteal nitinol stent implantation.
Rocha-Singh KJ; Beckman JA; Ansel G; Lyden SP; Schneider P; Mehta M; Dake M; Mullin CM; Jaff MR;
Catheter Cardiovasc Interv; 2017 Jun; 89(7):1250-1256. PubMed ID: 28303688
[TBL] [Abstract][Full Text] [Related]
22. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F
JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828
[TBL] [Abstract][Full Text] [Related]
23. One-Year Outcomes of the Paclitaxel-Eluting, Self-Expanding Stentys Stent System in the Treatment of Infrapopliteal Lesions in Patients With Critical Limb Ischemia.
Bosiers M; Callaert J; Keirse K; Hendriks JMH; Peeters P; Verbist J; Maene L; Beelen R; Deloose K
J Endovasc Ther; 2017 Jun; 24(3):311-316. PubMed ID: 28351310
[TBL] [Abstract][Full Text] [Related]
24. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial.
Laird JR; Katzen BT; Scheinert D; Lammer J; Carpenter J; Buchbinder M; Dave R; Ansel G; Lansky A; Cristea E; Collins TJ; Goldstein J; Jaff MR;
Circ Cardiovasc Interv; 2010 Jun; 3(3):267-76. PubMed ID: 20484101
[TBL] [Abstract][Full Text] [Related]
25. Bypass Versus Interwoven Nitinol Stents for Long Femoro-Popliteal Occlusions: A Propensity Matched Analysis.
Gostev AA; Osipova OS; Saaya SB; Bugurov SV; Cheban AV; Rabtsun AA; Ignatenko PV; Karpenko AA
Cardiovasc Intervent Radiol; 2022 Jul; 45(7):929-938. PubMed ID: 35581472
[TBL] [Abstract][Full Text] [Related]
26. Drug-Coated Balloon versus Bare Nitinol Stent in Femoropopliteal Artery: 12 Months Outcome from a Single Center in China.
Zhao H; Ma B; Chen J; Zheng L; Sun CR; Sun MS; Zhang JB; Fan XQ; Liu P; Ye ZD
Ann Vasc Surg; 2021 Jul; 74():367-381. PubMed ID: 33556529
[TBL] [Abstract][Full Text] [Related]
27. Endovascular treatment of popliteal artery segments P1 and P2 in patients with critical limb ischemia: initial experience using a helical nitinol stent with increased radial force.
Goltz JP; Ritter CO; Kellersmann R; Klein D; Hahn D; Kickuth R
J Endovasc Ther; 2012 Jun; 19(3):450-6. PubMed ID: 22788900
[TBL] [Abstract][Full Text] [Related]
28. Treatment of femoropopliteal atherosclerotic lesions using the ranger paclitaxel-coated balloon catheter: 12-month results from an all-comers registry.
Lichtenberg M; von Bilderling P; Ranft J; Niemöller K; Grell H; Briner L; Saucy F; Rassaf T; Breuckmann F
J Cardiovasc Surg (Torino); 2018 Feb; 59(1):45-50. PubMed ID: 28980462
[TBL] [Abstract][Full Text] [Related]
29. Treatment of the femoropopliteal artery with the bioresorbable REMEDY stent.
Bontinck J; Goverde P; Schroë H; Hendriks J; Maene L; Vermassen F
J Vasc Surg; 2016 Nov; 64(5):1311-1319. PubMed ID: 27462002
[TBL] [Abstract][Full Text] [Related]
30. Treatment for long-segment femoro-popliteal obstructions: initial experience with a 4-F compatible self-expanding nitinol stent and review of the literature.
Baumann F; Do DD; Willenberg T; Baumgartner I; Diehm N
J Cardiovasc Surg (Torino); 2012 Aug; 53(4):475-80. PubMed ID: 22854527
[TBL] [Abstract][Full Text] [Related]
31. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
[TBL] [Abstract][Full Text] [Related]
32. Stent placement in the superficial femoral and proximal popliteal arteries with the innova self-expanding bare metal stent system.
Powell RJ; Jaff MR; Schroë H; Benko A; Diaz-Cartelle J; Müller-Hülsbeck S
Catheter Cardiovasc Interv; 2017 May; 89(6):1069-1077. PubMed ID: 28296239
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the efficacy of combined device strategies for long femoropopliteal artery disease.
Iwata S; Suzuki R; Hosoi Y; Tanaka Y; Izumi Y; Tan M; Urasawa K
Cardiovasc Interv Ther; 2024 Jul; 39(3):273-283. PubMed ID: 38635112
[TBL] [Abstract][Full Text] [Related]
34. French multicenter experience with the GORE TIGRIS Vascular Stent in superficial femoral and popliteal arteries.
Sibé M; Kaladji A; Boirat C; Cardon A; Chaufour X; Bossavy JP; Saint-Lebes B
J Vasc Surg; 2017 May; 65(5):1329-1335. PubMed ID: 28222987
[TBL] [Abstract][Full Text] [Related]
35. Primary Patency of Long-Segment Femoropopliteal Artery Lesions in Patients with Peripheral Arterial Occlusive Disease Treated with Paclitaxel-Eluting Technology.
Phair J; Carnevale M; Lipsitz EC; Shariff S; Scher L; Garg K
Ann Vasc Surg; 2020 Jul; 66():595-600. PubMed ID: 31863948
[TBL] [Abstract][Full Text] [Related]
36. The use of the GORE® TIGRIS® Vascular Stent with dual component design in the superficial femoral and popliteal arteries at 6 months.
Piorkowski M; Freitas B; Schmidt A; Bräunlich S; Ulrich M; Schuster J; Bausback Y; Werner M; Scheinert D
J Cardiovasc Surg (Torino); 2013 Aug; 54(4):447-53. PubMed ID: 24013533
[TBL] [Abstract][Full Text] [Related]
37. A single center experience of Zilver PTX for femoro-popliteal lesions.
Kang WY; Campia U; Didier RJ; Kiramijyan S; Koifman E; Negi SI; Lipinski MJ; Baker NC; Escarcega RO; Torguson R; Waksman R; Bernardo NL
Cardiovasc Revasc Med; 2016 Sep; 17(6):399-403. PubMed ID: 27496591
[TBL] [Abstract][Full Text] [Related]
38. One-year results of primary stenting for TASC II D lesions of the superficial femoral and popliteal arteries.
Astarcıoglu MA; Kılıt C; Sen T; Durmus HI; Kalcık M; Gursoy MO; Yesın M; Asarcıklı LD; Gozubuyuk G; Amasyalı B
Acta Cardiol; 2017 Feb; 72(1):36-40. PubMed ID: 28597743
[TBL] [Abstract][Full Text] [Related]
39. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Pearl G; Theune B; Black S
J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
[TBL] [Abstract][Full Text] [Related]
40. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial.
Laird JR; Katzen BT; Scheinert D; Lammer J; Carpenter J; Buchbinder M; Dave R; Ansel G; Lansky A; Cristea E; Collins TJ; Goldstein J; Cao AY; Jaff MR;
J Endovasc Ther; 2012 Feb; 19(1):1-9. PubMed ID: 22313193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
